The fat mass- and obesity-associated (FTO) gene has primarily been studied for its role in regulating body mass and obesity, but recent research has begun to explore its broader impacts on metabolic diseases, including potential links to kidney disease. This evidence concerns the gene FTO and metabolic disease.